News from cempra, inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Jun 14, 2013, 09:29 ET

Cempra Prices Public Offering of Common Stock

 Cempra, Inc. (Nasdaq: CEMP), a clinical-stage pharmaceutical company focused on developing differentiated antibiotics to meet critical medical...

Jun 13, 2013, 16:02 ET

Cempra Provides Guidance on the Clinical Program Required for Regulatory Approval for Solithromycin for Community-Acquired Bacterial Pneumonia (CABP)

 Cempra, Inc. (Nasdaq: CEMP), a clinical-stage pharmaceutical company focused on developing differentiated antibiotics to meet critical medical...

Jun 13, 2013, 16:01 ET

Cempra Announces Proposed Public Offering of Common Stock

 Cempra, Inc. (Nasdaq: CEMP), a clinical-stage pharmaceutical company focused on developing differentiated antibiotics to meet critical...

May 30, 2013, 08:00 ET

Cempra, Inc., Announces Notification of Patent Allowance for U.S. Patent Application on Taksta Loading Dose Formulation

 Cempra, Inc., (Nasdaq: CEMP), a clinical-stage pharmaceutical company focused on developing differentiated antibiotics to meet critical...

May 29, 2013, 16:05 ET

Cempra, Inc. to Present at Jefferies 2013 Global Healthcare Conference

Cempra, Inc. (Nasdaq: CEMP) today announced that Prabhavathi Fernandes, Ph.D., president and chief executive officer of Cempra, will present at the...

May 28, 2013, 09:15 ET

Cempra Awarded $58 Million Contract to Develop Antibiotic for Pediatric Use and Biodefense by Biomedical Advanced Research and Development Authority (BARDA)

 Cempra, Inc. (Nasdaq: CEMP), a clinical-stage pharmaceutical company focused on developing differentiated antibiotics, today announced that...

May 20, 2013, 08:00 ET

Cempra Presents Post-Phase 2 Analysis of Solithromycin's Efficacy and Safety Results from Patients with Community Acquired Bacterial Pneumonia (CABP)

Cempra, Inc. (Nasdaq: CEMP), a clinical-stage pharmaceutical company focused on developing differentiated antibiotics to meet critical medical...

May 13, 2013, 16:05 ET

Cempra, Inc. Signs Exclusive License and Development Agreement for Solithromycin with Toyama Chemical Co., Ltd., a subsidiary of FUJIFILM Holdings Corporation in Japan

 Cempra, Inc. (Nasdaq: CEMP), a clinical-stage pharmaceutical company focused on developing differentiated antibiotics to meet critical needs...

Apr 26, 2013, 19:01 ET

Cempra to Present Data on Solithromycin's (CEM-101) Potential Against Urogenital Infections and Multidrug-Resistant Pathogens at ECCMID

Cempra, Inc. (Nasdaq: CEMP), a clinical-stage pharmaceutical company focused on developing differentiated antibiotics to meet critical medical...

Apr 25, 2013, 16:05 ET

Cempra, Inc. Reports First Quarter 2013 Financial and Operating Results

 Cempra, Inc. (Nasdaq: CEMP), a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the...

Apr 24, 2013, 16:05 ET

Cempra, Inc. to Present at 12th Annual Needham Healthcare Conference

 Cempra, Inc. (Nasdaq: CEMP) today announced that Prabhavathi Fernandes, Ph.D., president and chief executive officer of Cempra, will present...

Apr 18, 2013, 16:05 ET

Cempra, Inc. to Report First Quarter 2013 Financial and Operating Results, and Host Conference Call and Webcast on April 25, 2013

 Cempra, Inc. (Nasdaq: CEMP) today announced that it will report first quarter 2013 financial results and provide a business update after...

Feb 28, 2013, 16:05 ET

Cempra, Inc. Reports Fourth Quarter and Full Year 2012 Financial and Operating Results

 Cempra, Inc. (Nasdaq: CEMP), a clinical-stage pharmaceutical company focused on developing differentiated antibiotics to meet...

Feb 26, 2013, 16:05 ET

Cempra, Inc. to Present at Cowen and Company 33rd Annual Health Care Conference

 Cempra, Inc. (Nasdaq: CEMP) today announced that Prabhavathi Fernandes, Ph.D., president and chief executive officer of Cempra, will present...

Feb 21, 2013, 16:05 ET

Cempra, Inc. to Report Fourth Quarter and Full Year 2012 Financial and Operating Results, and Host Conference Call and Webcast on February 28, 2013

Cempra, Inc. (Nasdaq: CEMP) today announced that it will report fourth quarter and full year 2012 financial results and provide a business...

Feb 12, 2013, 08:00 ET

Grant Awarded to Study Novel Therapies for Muco-Obstructive Diseases Includes Studies on Cempra's Solithromycin (CEM-101) in a Cystic Fibrosis Anti-inflammatory Model

Cempra, Inc. (Nasdaq: CEMP), a clinical-stage pharmaceutical company focused on developing differentiated antibiotics to meet critical medical...

Feb 05, 2013, 16:05 ET

Cempra, Inc. to Present at BIO CEO & Investor Conference and Leerink Swann Global Healthcare Conference

Cempra, Inc. (Nasdaq: CEMP) today announced that Prabhavathi Fernandes, Ph.D., president and chief executive officer, will present at the BIO CEO...

Dec 19, 2012, 08:00 ET

Cempra, Inc. Announces Initiation of Oral Solithromycin Global Phase 3 Clinical Trial in Patients with Community-Acquired Bacterial Pneumonia

 Cempra, Inc. (Nasdaq: CEMP), a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the...

Dec 14, 2012, 08:00 ET

Cempra, Inc. Announces Initiation of CEM-102 Phase 2 Clinical Trial in Patients with Prosthetic Joint Infections

 Cempra, Inc. (Nasdaq: CEMP), a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the...

Dec 05, 2012, 16:00 ET

Cempra, Inc. to Present at Oppenheimer 23rd Annual Healthcare Conference

 Cempra, Inc. (Nasdaq: CEMP) today announced that Prabhavathi Fernandes, Ph.D., president and chief executive officer of Cempra, will present...